France COVID-19 diagnostics market is estimated to see a decline in CAGR of 27.5% during the forecast period. COVID-19 testing has emerged rapidly in France owing to the surge in the daily COVID-19 incidences and government initiatives for free testing of coronavirus. An increasing number of private clinics and laboratories in the country are offering coronavirus tests, which is supporting suspected COVID-19 patients to get easy access to proper diagnostic tests. After the outbreak of COVID-19, France took some major steps that supported increasing access to testing to the public. After easing the lockdown measure, the rate of COVID-19 infections is rising significantly and therefore, the demand for COVID-19 testing tools is accelerating in the country. The country has also implemented airport testing to minimize the spread of the virus from travelers. From August 01, 2020, France started COVID-19 testing for travelers who are entering the country from 16 countries where the coronavirus is spreading significantly. The travelers from these countries must undergo virus tests upon arrival at French ports and airports. As a result of this rule, France's Charles-de-Gaulle airport started compulsory testing for Covid-19 on arrival for passengers from 16 countries. This leads to an increasing scope of COVID-19 testing in the country.

France COVID-19 diagnostics market is segmented based on technology type, end-use, sample type, and product type. By end-use, the COVID-19 diagnostic market is divided into laboratories, hospitals, diagnostic centers & clinics, and research institutes. By product type, the market is further segmented into instruments, reagents & kits, and laboratory testing services. By Sample type, the market is divided into oropharyngeal & nasopharyngeal swabs, blood, urine, saliva, and others. By technology type, the market is further segmented into PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test. Among these, the PCR segment has a major share in the COVID-19 diagnostics market. The factor that enhances the PCR test adoption includes a wide availability of tests and generation of the accurate results. However, due to its time consuming and expensive nature, these tests are substituted with other tests such as serology tests.

The companies which are contributing to the growth of the France COVID-19 diagnostics market include bioMérieux SA, GeneStore France SAS, Eurobio Scientific SA, Sanofi SA, and NG Biotech. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups, and technological advancements to stay competitive in the market. For instance, in June 2020, GeneStore France SAS, launched affordable Made in France, COVID-19 RT-PCR Test Kit at nearly $11.2. It delivers results in 1 hour and is based on a multiplexed one-step RT-PCR approach. The initiative to launch this affordable testing is to facilitate higher volumes of testing across the globe. This CE-IVD marked test is now being shipped across the EU, Africa, Southeast Asia, and Latin America to expedite availability. The company can produce 1 million test kits per month at its France-based manufacturing facility.

Research Methodology

The market study of the France COVID-19 diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, various services offered by the players, and market opportunity. The report will serve as a source for 360-degree analysis of the market delivering insights for making better business decisions.

Market Segmentation

1. France COVID-19 Diagnostics Market Research and Analysis by Type
2. France COVID-19 Diagnostics Market Research and Analysis by Technology Type
3. France COVID-19 Diagnostics Market Research and Analysis by Sample Type
4. France COVID-19 Diagnostics Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the France COVID-19 diagnostics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the France COVID-19 diagnostics market.
• Insights about market determinants which are stimulating the France COVID-19 diagnostics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.